CHRNA7 and Alzheimer disease: Though the blockage of α7nAChR in normal rats by the selective blocker methyllycaconitine (MLA) has induced an in vivo model of cognitive impairment [28]; however, the interaction of increased fibrillary Aβ complexes with α7nAChR in AD rats contributed to synaptic dysfunction [26].